Cigna (CI Quick QuoteCI - Free Report) reported $60.47 billion in revenue for the quarter ended June 2024, representing a year-over-year increase of 24.4%. EPS of $6.72 for the same period compares to $6.13 a year ago.

The reported revenue compares to the Zacks Consensus Estimate of $58.49 billion, representing a surprise of +3.39%. The company delivered an EPS surprise of +4.67%, with the consensus EPS estimate being $6.42.

While investors scrutinize revenue and earnings changes year-over-year and how they compare with Wall Street expectations to determine their next move, some key metrics always offer a more accurate picture of a company's financial health.

Since these metrics play a crucial role in driving the top- and bottom-line numbers, comparing them with the year-ago numbers and what analysts estimated about them helps investors better project a stock's price performance.

Here is how Cigna performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts:

• Medical Care Ratio - Cigna Healthcare

  : 82.3% compared to the 82.2% average estimate based on eight analysts.

• Covered Lives By Market Segment - Medical Customers - International Health

  : 1.64 million versus the four-analyst average estimate of 1.62 million.

• Medical Customers - Total

  : 19.04 million versus 19.22 million estimated by four analysts on average.

• Total Medical Customers - Medicare Part D

  : 2.56 million versus 2.56 million estimated by three analysts on average.

• Revenues- Pharmacy

  : $45.10 billion versus the six-analyst average estimate of $43.10 billion. The reported number represents a year-over-year change of +32.8%.

• Revenues- Evernorth Health Services

  : $49.55 billion versus $47.39 billion estimated by six analysts on average. Compared to the year-ago quarter, this number represents a +29.7% change.

• Revenues- Net investment income

  : $321 million versus the six-analyst average estimate of $287.49 million. The reported number represents a year-over-year change of +15.5%.

• Revenues- Fees and Other

  : $3.65 billion compared to the $3.53 billion average estimate based on six analysts. The reported number represents a change of +10.4% year over year.

• Revenues- Premiums

  : $11.45 billion versus $11.63 billion estimated by six analysts on average. Compared to the year-ago quarter, this number represents a +3.8% change.

• Revenues- Cigna Healthcare- Premiums

  : $11.45 billion versus $11.54 billion estimated by six analysts on average. Compared to the year-ago quarter, this number represents a +4.7% change.

• Revenues- Evernorth Health Services- Pharmacy

  : $46.19 billion versus $44.58 billion estimated by five analysts on average. Compared to the year-ago quarter, this number represents a +31% change.

• Revenues- Cigna Healthcare

  : $13.20 billion versus the four-analyst average estimate of $13.23 billion. The reported number represents a year-over-year change of +4%.

View all Key Company Metrics for Cigna here>>>

Shares of Cigna have returned +7.1% over the past month versus the Zacks S&P 500 composite's +1.1% change. The stock currently has a Zacks Rank #2 (Buy), indicating that it could outperform the broader market in the near term.